Medical Oncologist Specializing in Prostate Cancer
Oncology
Dr. Stephen B. Strum, MD
Stephen Strum is an expert in the field of Oncology. He researched medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. Doctor Stephen B. Strum, MD is a published MD as well. He has 15 publications published. The latest was: Consultation and patient information on the Internet: the patients'' forum.
Publications
- Erratum to: Case Report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human Cancer patient: complete response in non-Hodgkin's lymphoma after d...
- Primary androgen deprivation (AD) Followed by active surveillance (AS) for newly diagnosed Prostate cancer (PC): A retrospective study.
- Case Report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human Cancer patient: complete response in non-Hodgkin's lymphoma after disease progr...
- Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer.
- Intermittent use of testosterone inactivating pharmaceuticals using finasteride prolongs the time off period.
- Maniacs, malignancy, medicine.
- Consultation and patient information on the Internet: the patients'' forum.
- Re: Recovery of spontaneous erectile function after nerve-sparing radical retropubic Prostatectomy with and without early intracavernous injections of alprostadil: res...
- Modified citrus pectin (MCP) increases the Prostate-specific antigen doubling time in men with Prostate cancer: a phase II pilot study.
- Re: Prostate specific antigen: a decade of discovery--what we have learned and where we are going.
- Prostate-cancer-specific survival and clinical progression-free survival in men with Prostate cancer treated intermittently with testosterone-inactivating pharmaceutic...
- Anaemia associated with androgen deprivation in patients with Prostate cancer receiving combined hormone blockade.
- Intermittent androgen deprivation in Prostate cancer patients: factors predictive of prolonged time off therapy.
- Long-term outcome for men with androgen independent Prostate cancer treated with ketoconazole and hydrocortisone.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Conditions Treated
- Anemia
- Prostate Cancer
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Southern California - LAC+USC Medical Center -
University of Chicago -
University of Chicago Pritzker School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Dawn Lemanne, MD
 This Doctor is OpenDoctor Recommended.
|